Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giralt

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Impact of high-dose chemotherapy on peripheral T-cell lymphomasJ Rodriguez, M Munsell, S Yazji, et al.
Leukemia|July 6, 2007
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantationB Oran, S Giralt, D Couriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignanciesI F Khouri, M Keating, M Körbling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.
Blood|February 9, 2000
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusionsD L Porter, R H Collins, C Hardy, et al.
Bone Marrow Transplantation|October 26, 2005
The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter studyG J Ruiz-Argüelles, D Gómez-Almaguer, A Morales-Toquero, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Blood|January 11, 2000
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registryS Giralt, R Szydlo, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Impact of high-dose chemotherapy on peripheral T-cell lymphomasJ Rodriguez, M Munsell, S Yazji, et al.
Leukemia|July 6, 2007
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantationB Oran, S Giralt, D Couriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignanciesI F Khouri, M Keating, M Körbling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.
Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.
Blood|February 9, 2000
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusionsD L Porter, R H Collins, C Hardy, et al.
Bone Marrow Transplantation|October 26, 2005
The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter studyG J Ruiz-Argüelles, D Gómez-Almaguer, A Morales-Toquero, et al.
Pageof 18